Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban center.
Fabian SchnitzlerCornelia Tillack-SchreiberDaniel SzokodiIsabel BraunJune TomeldenMaximilian SohnFranz BaderConstanze Heike WaggershauserThomas OchsenkühnPublished in: PloS one (2024)
This retrospective single center study of 447 IBD patients goes to demonstrate that perioperative use of biologics is not associated with a higher risk of complications.
Keyphrases
- patients with inflammatory bowel disease
- end stage renal disease
- cardiac surgery
- patients undergoing
- ejection fraction
- chronic kidney disease
- minimally invasive
- peritoneal dialysis
- prognostic factors
- cross sectional
- risk factors
- coronary artery bypass
- coronary artery disease
- percutaneous coronary intervention
- patient reported